Ocean Biomedical, Inc. Common Stock
OCEA
OCEA was delisted on the 23rd of April, 2025.
35 hedge funds and large institutions have $3.06M invested in Ocean Biomedical, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 7 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 8
10% less funds holding
Funds holding: 39 → 35 (-4)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
87% less capital invested
Capital invested by funds: $24.2M → $3.06M (-$21.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$86.8K |
| 2 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$45.7K |
| 3 |
Mariner
Overland Park,
Kansas
|
+$40.7K |
| 4 |
Two Sigma Investments
New York
|
+$35K |
| 5 |
VF
Virtu Financial
New York
|
+$31.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$1.76M |
| 2 |
QL
Quarry LP
New York
|
-$897K |
| 3 |
BlackRock
New York
|
-$282K |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$45.6K |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$24.1K |
OCEA Hedge Fund Activity: Q4 2023 in Review
35 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q4 2023, worth a combined $3.06M — down 87% from $24.2M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of OCEA and 5 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 14 added.
The largest buyer was Morgan Stanley, adding an estimated $86.8K. The largest seller was Meteora Capital, cutting an estimated $1.76M.
- 35 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q4 2023, down from 39 in Q3 2023.
- Funds reported $3.06M of Ocean Biomedical, Inc. Common Stock stock for Q4 2023, down 87% quarter-over-quarter.
- 5 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q4 2023 and 7 closed out, a net change of -2 holders.
- The largest Ocean Biomedical, Inc. Common Stock buyer in Q4 2023 was Morgan Stanley, an estimated $86.8K added.
- The largest Ocean Biomedical, Inc. Common Stock seller in Q4 2023 was Meteora Capital, an estimated $1.76M sold.
Based on aggregated 13F filings for Q4 2023.